Company Filing History:
Years Active: 2022
Title: Inventor La Ma: Pioneering Research in Biopharmaceuticals
Introduction: La Ma, an innovative inventor based in Guangdong, China, has made significant contributions to the field of biopharmaceuticals. With a focus on recombinant human-basic fibroblast growth factor (rh-bFGF), La Ma holds a patent that has the potential to impact medical research and treatment modalities.
Latest Patents: La Ma is credited with a patent for a novel method of producing a soluble recombinant human-basic fibroblast growth factor (rh-bFGF). The patent encompasses not only the method itself but also the recombinant human-basic fibroblast growth factor obtained through this process, as well as a mutated nucleic acid molecule encoding the rh-bFGF. This advancement is crucial for therapeutic applications and offers new pathways for research in regenerative medicine.
Career Highlights: La Ma is associated with Zhuhai Essex Bio-Pharmaceutical Co., Ltd., where innovative research and development are at the forefront. Her work has positioned her as a key player in biological sciences, contributing to advancements that can improve patient outcomes and enhance treatment effectiveness.
Collaborations: Throughout her career, La Ma has collaborated with esteemed colleagues such as Haizhou Fang and Bo Yang. These partnerships highlight her commitment to fostering a collaborative research environment, which is essential for pioneering innovative solutions in biotechnology.
Conclusion: La Ma's inventive spirit and dedication to biopharmaceutical research are evident through her patent and collaborative efforts. By developing methods that enhance the production of crucial growth factors, she is contributing to significant advancements in medical science. As her career progresses, La Ma continues to be a notable figure in the field, inspiring future innovations and fostering improvements in healthcare.